Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Amer Bio Medica

Healthcare US ABMC

NoneUSD
0.00(0%)

Last update at 2025-08-04T13:01:45.171886Z

Day Range

--
LowHigh

52 Week Range

0.00010.02
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap0.00962M
  • VolumeNone
  • P/E Ratio0.01
  • Dividend Yield4.50%
  • EBITDA-1.16700M
  • Revenue TTM0.73M
  • Revenue Per Share TTM0.01
  • Gross Profit TTM -0.19300M
  • Diluted EPS TTM0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -1.40800M -0.46100M -0.79400M -0.68600M -1.02600M
Minority interest - - - - -
Net income -1.41000M -0.46300M -0.79600M -0.68100M -1.02800M
Selling general administrative 0.92M 1.34M 1.28M 1.24M 1.41M
Selling and marketing expenses 0.14M 0.30M 0.49M 0.46M 0.55M
Gross profit -0.19300M 0.55M 1.24M 1.18M 1.29M
Reconciled depreciation 0.05M 0.07M 0.08M 0.08M 0.08M
Ebit -1.24200M -1.17900M -0.70000M -0.67400M -0.84300M
Ebitda -1.16300M -0.43400M -0.62100M -0.59300M -0.76200M
Depreciation and amortization 0.08M 0.74M 0.08M 0.08M 0.08M
Non operating income net other - - -0.17300M -0.09300M -0.26400M
Operating income -1.24200M -1.17900M -0.62100M -0.59300M -0.76200M
Other operating expenses 2.25M 3.40M 4.77M 4.25M 4.63M
Interest expense 0.19M 0.19M 0.17M 0.27M 0.28M
Tax provision 0.00200M 0.00200M 0.00200M -0.00500M 0.00200M
Interest income 0.00300M - - 0.00000M 0.00100M
Net interest income -0.19100M -0.19400M -0.17500M -0.26500M -0.28300M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00200M 0.00200M 0.00200M -0.00500M 0.00200M
Total revenue 0.91M 2.22M 4.15M 3.65M 3.87M
Total operating expenses 1.14M 1.73M 1.86M 1.78M 2.05M
Cost of revenue 1.11M 1.67M 2.91M 2.47M 2.58M
Total other income expense net -0.16600M 0.72M -0.17300M -0.09300M -0.26400M
Discontinued operations - - - - -
Net income from continuing ops -1.41000M -0.46300M -0.79600M -0.68100M -1.02800M
Net income applicable to common shares -1.41000M -0.46300M -0.79600M -0.68100M -1.02800M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 1.27M 1.88M 1.93M 2.08M 2.48M
Intangible assets - - 0.11M 0.12M 0.12M
Earning assets - - - - -
Other current assets 0.07M 0.06M 0.14M 0.04M 0.03M
Total liab 3.61M 2.83M 3.18M 2.87M 2.62M
Total stockholder equity -2.33900M -0.94400M -1.25600M -0.79000M -0.14600M
Deferred long term liab - - - - -
Other current liab 0.61M 0.51M 0.56M 0.64M 0.70M
Common stock 0.48M 0.48M 0.38M 0.33M 0.32M
Capital stock 0.48M 0.48M 0.38M 0.33M 0.32M
Retained earnings -25.22300M -23.81300M -23.35000M -22.55400M -21.87300M
Other liab - - - - -
Good will - - - - -
Other assets 0.02M 0.02M 0.02M -0.00300M 0.02M
Cash 0.03M 0.12M 0.10M 0.00400M 0.11M
Cash and equivalents - - - - -
Total current liabilities 3.60M 2.82M 2.02M 1.69M 1.82M
Current deferred revenue - 0.05M 0.17M 0.01000M 0.03M
Net debt 2.21M 1.47M 1.78M 1.56M 1.42M
Short term debt 2.23M 1.58M 0.72M 0.39M 0.74M
Short long term debt 2.23M 1.54M 0.68M 0.35M 0.74M
Short long term debt total 2.24M 1.58M 1.88M 1.57M 1.53M
Other stockholder equity 22.40M 22.39M 21.72M 21.44M 21.40M
Property plant equipment 0.48M 0.52M 0.58M 0.72M 0.72M
Total current assets 0.77M 1.34M 1.18M 1.23M 1.61M
Long term investments - - - - -
Net tangible assets -2.33900M -0.94400M -1.36400M -0.90600M -0.26900M
Short term investments - - - - -
Net receivables 0.28M 0.72M 0.41M 0.37M 0.45M
Long term debt - - 1.12M 1.11M 0.79M
Inventory 0.38M 0.44M 0.54M 0.81M 1.02M
Accounts payable 0.76M 0.68M 0.58M 0.65M 0.36M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - 0.38M 0.33M 0.32M
Preferred stock total equity - - - - -
Retained earnings total equity - - -23.35000M -22.55400M -21.87300M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.02M 0.02M 0.02M 0.02M 0.02M
Deferred long term asset charges - - - - -
Non current assets total 0.50M 0.54M 0.75M 0.85M 0.86M
Capital lease obligations 0.01000M 0.04M 0.07M 0.11M -
Long term debt total - - 1.12M 1.11M 0.79M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments - 0.00000M -0.00400M 0.00000M -0.02200M
Change to liabilities 0.08M 0.10M -0.02700M 0.21M 0.14M
Total cashflows from investing activities - - -0.00400M -0.00400M -0.02200M
Net borrowings 0.69M 0.59M 0.38M -0.16700M 0.12M
Total cash from financing activities 0.69M 0.69M 0.58M -0.16700M 0.32M
Change to operating activities 0.19M -0.48100M -0.01900M -0.05700M 0.25M
Net income -1.41000M -0.46300M -0.79600M -0.68100M -1.02800M
Change in cash -0.08100M 0.02M 0.09M -0.10900M 0.08M
Begin period cash flow 0.12M 0.10M 0.00400M 0.11M 0.04M
End period cash flow 0.03M 0.12M 0.10M 0.00400M 0.11M
Total cash from operating activities -0.76800M -0.67300M -0.48300M 0.06M -0.22000M
Issuance of capital stock 0.00000M 0.10M 0.20M 0.00000M 0.20M
Depreciation 0.05M 0.07M 0.08M 0.08M 0.08M
Other cashflows from investing activities - - - - -0.02200M
Dividends paid - - - - -
Change to inventory 0.11M 0.09M 0.12M 0.11M 0.32M
Change to account receivables 0.24M 0.10M -0.04000M 0.08M -0.08800M
Sale purchase of stock - - 0.20M - 0.20M
Other cashflows from financing activities 1.86M 2.83M 4.43M 3.92M 4.28M
Change to netincome -0.02900M -0.09700M 0.00500M 0.00400M -0.00600M
Capital expenditures 0.00000M 0.00000M 0.00400M 0.00400M 0.02M
Change receivables - - -0.04000M 0.08M -0.08800M
Cash flows other operating - - 0.16M 0.14M 0.23M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - 0.09M -0.10900M 0.08M
Change in working capital 0.62M -0.18100M -0.01700M 0.43M 0.47M
Stock based compensation - 0.00000M 0.00200M 0.00600M 0.01000M
Other non cash items -0.02900M -0.09700M 0.09M 0.12M 0.13M
Free cash flow -0.76800M -0.67300M -0.48700M 0.06M -0.24200M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ABMC
Amer Bio Medica		 - -% - 0.01 - 0.01 - 0.16 0.11
TMO
Thermo Fisher Scientific Inc		 5.34 1.15% 469.35 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation		 0.78 0.44% 178.97 29.09 28.01 5.67 3.20 6.00 19.09
A
Agilent Technologies Inc		 0.18 0.14% 126.67 34.36 26.39 6.59 7.14 6.78 23.56
IDXX
IDEXX Laboratories Inc		 -5.19 0.95% 540.54 49.99 45.66 11.29 27.85 11.46 34.46

Reports Covered

Stock Research & News

View All

Profile

American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers a test for the detection of respiratory syncytial virus; OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides strip contract manufacturing, assembly, and packaging services to unaffiliated diagnostic companies. The company serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets. It operates in the United States, North America, Europe, the Asia Pacific, and South America. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York.

Amer Bio Medica

122 Smith Road, Kinderhook, NY, United States, 12106

Key Executives

Name Title Year Born
Ms. Melissa A. Waterhouse CEO, Principal Accounting & Financial Officer and Director 1971
Ms. Jean Neff Corp. Sec. & Independent Director 1943
Mr. J. Duncan Urquhart Controller 1954

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.